MedTech analysis

Spinal Motion Preservation Devices Market

Sales of spinal motion preservation devices totaled $1.7bn in 2019, with sales expected to climb at a CAGR of 2.0% during 2019-2024.

May 18, 2022

Neuromodulation: Spinal Cord Stimulation Devices Market

According to a recent CDC study, 20.1% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities with similar numbers being reported in Europe. In 2021, the spinal cord stimulation (SCS) devices market was worth nearly $2.9 bn. Market drivers of the SCS devices market through 2026 will be driven by an aging population and an increase in selected conditions (eg back/leg pain, and a growing number of indications) that result in debilitating and unrelenting chronic pain.

February 22, 2022

U.S. Surgical Procedure Volumes

This report presents the most common surgical procedures performed in the United States (U.S.) as well as an overview of the etiology and epidemiology of selected diseases/disorders, prevailing surgical approaches/techniques, and evolving procedural utilization trends.

November 1, 2015

U.S. Markets for Interventional Peripheral Vascular Disease Management Products and Technologies

This dynamic, new report from Medtech Insight includes analyses of products, current and forecast markets, competitors, and opportunities in the U.S. interventional peripheral vascular disease management arena.

Women’s Health: Market for Minimally Invasive Female Urinary Incontinence Devices

$3,750.00

This report focuses on minimally invasive therapy systems designed for the treatment of female urinary incontinence (UI); market segments covered include injectable urethral bulking agents, urethral sling systems, and neuromodulation systems.

December 19, 2016

U.S. Neurostimulation Devices Market, June 2015

$5,250.00

An estimated 200 million people in the United States (U.S.) experience some degree of neurological impairment over the course of a lifetime.

Q3 2021 Outlook Report

In this report, we cover catalysts from 27 drugs, devices, diagnostics, and deals expected to occur in the third quarter of 2021. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

June 2, 2021

2019 Biomedtracker / Datamonitor Healthcare Post-ESMO Report

The Annual European Society for Medical Oncology (ESMO) 2019 Congress was held in Barcelona, Spain from September 27 to October 1, 2019. Conference highlights included new data from PARP inhibitors in ovarian cancer, such as Zejula, Lynparza and veliparib, as well as a follow-up update for KRAS-targeted drug AMG 510 for colorectal cancer, and CDK4/6-inhibitors, Kisqali and Verzenio, for breast cancer. Key pipeline updates for more established drugs were highly featured including Keytruda for…

October 18, 2019

U.S. Markets for Obesity Drugs & Devices

$5,250.00

U.S. Markets for Obesity Drugs & Devices

U.S. Markets for Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening

$3,750.00

This dynamic, new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportunities in the U.S. diagnostic ultrasound, minimally invasive biopsy, and tissue screening products arena.

Global Market for Fracture Fixation Devices

This Meddevicetracker report provides an analysis of the market for fracture fixation devices, including external fixation and internal fixation devices. Geographic segments covered include the US, five major EU markets, Japan, and the rest of the world.The global fracture fixation devices market is expected to increase at a CAGR of 5.9% over the five-year forecast period, reaching nearly $11bn in 2023. Competition is increasing in fracture fixation, as major orthopedic suppliers enter the market to take advantage of cross-selling opportunities, and manufacturers from other specialties, such as arthroscopy and spine, launch new products.

August 28, 2019

2018 Biomedtracker Datamonitor Healthcare Post-ASH Report

$599.00

The 60th American Society of Hematology (ASH) Annual Meeting and Exposition was held in San Diego, CA from December 1-4, 2018.

January 3, 2019

Type 1 Diabetes KOL Interview – US, Midwest

$599.00

This interview with a US Key Opinion Leader (KOL) provides insight into current therapies for type 1 diabetes, as well as pricing pressures within the diabetes market.

January 8, 2020

Germany, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and interventional procedures in Germany; incidence and prevalence figures are compared with those of the Benelux countries

November 1, 2012